NICE will review whether new Alzheimer’s drugs should be offered on the NHS after an appeal found their wider impact was not fully counted. An appeal...
Atrogi has dosed the first volunteers in a human trial of ATR-258, a muscle-preserving drug designed to help people lose fat without losing muscle. The eight-week...
MINNESOTA-based Medtronic has agreed to acquire neurovascular technology company Scientia Vascular for US$550m. Scientia’s neurovascular access devices are used to navigate the brain’s complex vasculature, helping...
A new report by Clue has revealed the ‘Cost of Bleeding’ – a deep dive into the true cost of menstruation and the impact of related...
Osteoporosis drugs may lower dementia risk, with a study suggesting one widely used treatment could help prevent Alzheimer’s and related dementias. The research found that nitrogen-containing...
Routine blood pressure checks could help flag dementia risk, according to two studies tracking changes in blood vessel stiffness over time. The findings add to growing...
A prebiotic fibre supplement may ease arthritis pain and improve grip strength in people with knee osteoarthritis, a study suggests. The daily supplement, made from inulin,...
An NHS diabetes drug costing as little as 2p a tablet could cut prostate cancer risk by more than a third, a study suggests. Metformin is...
MemoryAid, a phone-like device for dementia care, has shown positive trial results and is due to launch to the public this year. Developed by a team...
Vision-restoration company Science Corp has closed a US$230m Series C financing round which will allow it to complete the commercialisation of its brain-computer interface, retinal implant,...
